New MOU Underscores Benefits of RavenQuest BioMed’s Four Pillar Approach


Ryan Allway

April 4th, 2018

Exclusive, News, Top News


The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. With a growing number of licensed producers in the space, competition is intensifying across the industry to scale up production. Investors may want to focus on companies that have taken a differentiated approach to delivering long-term shareholder value.

RavenQuest BioMed Inc. (CSE: RQB) has developed a synergistic four-pillar approach to the cannabis industry that sets it apart from other licensed producers. With a focus on Indigenous People’s partnerships, investments in near-term cultivation, immediate revenue from management services, and ongoing research and development, investors may want to take a closer look at the company following its recent partnership with an Indigenous group.

Indigenous Populations

RavenQuest BioMed has developed an indigenous-centered, end-to-end solution for cannabis production and sale on sovereign land. As part of these programs, the company provides sovereign nations with the technical know-how, staff resources, and financing opportunities in exchange for a percentage ownership in the facilities. These partnerships could lead to a steady stream of positive announcements of new production licenses over the coming quarters.

Under the guidance of Bill Robinson, the company has already identified and engaged with an impressive list of prospective Indigenous Peoples partners. Mr. Robinson serves as the head of Government/Indigenous Relations and Strategic Partnerships with over 34 years of experience with the Royal Canadian Mounted Police (RCMP). During this career, he worked closely with many organizations and developed close and trusted relationships with these communities.

Management anticipates that many of these engagements will begin as simple service contracts to build facilities that evolve into partnerships with equity interests. In other words, the services division is expected to generate deal flow for the investment division, which helps create both near-term and long-term value for shareholders. These trends have already been realized with its recent partnership with Fort McMurray #468 First Nation.

Fort McMurray Expansion

RavenQuest BioMed recently announced a Memorandum of Understanding with Fort McMurray #468 First Nation to collaboration in the development, operation, and financing of a purpose-built facility for the production of cannabis on its land. Under the terms of the agreement, the company will receive a 30 percent ownership stake in the 24,000 sq. ft. facility, which will be rapidly expanded to a maximum of 250,000 sq. ft.

“This MOU represents a key milestone for our organization,” said RavenQuest CEO George Robinson in a recent press release. “We intend to emerge as the trusted provider of choice for Indigenous Peoples’ cannabis industry partnerships across Canada … With the right partners, we see cannabis as a tremendous opportunity for economic diversification, self-reliance, employment, and harm reduction within Indigenous communities.”

Management believes that the facility will produce 50,000 kilograms of dried cannabis per year. Through its 30 percent stake, the company would be entitled to about 15,000 kilograms per year of that production. The company’s total production, along with its existing 11,000 kilograms per year facilities, bring the total to 26,000 kilograms per year at full capacity. The deal also paves the way for future projects as a valuable proof-of-concept.

Looking Ahead

RavenQuest BioMed Inc.’s (CSE: RQB) recent deal with Fort McMurray #468 First Nation underscores the company’s ability to execute on its Indigenous Peoples’ agreements, as well as shows how the company’s four pillars work together. Investors may want to take a closer look at the stock given these developments and the potential for near-term revenue and long-term shareholder value.
For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading